Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Biogen
Biogen
Who are the 10 Most Innovative Biopharma Companies?
BioSpace
Fri, 01/17/20 - 11:41 pm
innovation
Regeneron
Verily
Illumina
Biogen
Bayer
Bluebird Bio
Novartis
GSK
Genentech
Amgen
Analysts tip Biogen to file for aducanumab approval within weeks
Fierce Biotech
Thu, 01/16/20 - 10:10 am
Biogen
Alzheimer's disease
aducanumab
FDA
JPM: Already prepping for Alzheimer's launch, Biogen scouts 'top talent' and talks pricing
Fierce Pharma
Tue, 01/14/20 - 10:49 am
Biogen
Alzheimer's disease
drug pricing
aducanumab
JPMHC 2020
Roche aims to 'underwhelm' with risdiplam price as it enters SMA rivalry with Biogen, Novartis — report
Endpoints
Tue, 01/14/20 - 10:20 am
SMA
Roche
risdiplam
Biogen
Novartis
drug pricing
New MS Trial Will be First to Compare Stem Cell Therapy with Best Available Biologics
Xtalks
Mon, 01/13/20 - 11:35 pm
stem cells
MS
multiple sclerosis
NIH
AHSCT
Biogen
Tysabri
Sanofi
Lemtrada
Roche
Ocrevus
Rituxan
Biogen makes another Alzheimer's bet, paying Pfizer $75M for early-phase drug
Fierce Biotech
Mon, 01/13/20 - 10:51 am
Biogen
Alzheimer's disease
Pfizer
PF-05251749
A Preview Of JPMorgan's Healthcare Conference: Focus On Value-Creating Themes, 2020 Expectations
Yahoo/Benzinga
Sat, 01/11/20 - 11:02 pm
JPMHC 2020
Bristol-Myers Squibb
Vertex Pharmaceuticals
Biomarin
Regeneron
Biogen
Alexion
Gilead Sciences
Amgen
Biogen Teams Up With Startup CAMP4 to Scout for New Neuro Drugs
Xconomy
Fri, 01/10/20 - 10:18 am
Biogen
Neuroscience
CAMP4 Therapeutics
drug development
Biogen and the desperation of a need for Alzheimer's drugs
Fierce Biotech
Fri, 12/20/19 - 08:13 pm
Biogen
FDA
Alzheimer's disease
aducanumab
After Recent Tau Failure, Biogen Licenses Tau Therapeutic from Ionis for Alzheimer's Disease
BioSpace
Thu, 12/19/19 - 01:04 pm
Biogen
Alzheimer's disease
IONIS-MAPTRx
Ionis Pharmaceuticals
Biogen chalks up another failure, but investors' eyes remain firmly on Alzheimer's
Fierce Biotech
Fri, 12/13/19 - 12:26 pm
Biogen
Alzheimer's disease
aducanumab
progressive supranuclear palsy
gosuranemab
clinical trials
Biogen Points to Enrollment and Dosing to Explain Alzheimer’s Results
Xconomy
Thu, 12/5/19 - 11:35 pm
Biogen
Alzheimer's disease
aducanumab
Worldwide Clinical Trials
The clearest picture of Biogen's Alzheimer's drug is still fuzzy
Biopharma Dive
Thu, 12/5/19 - 11:34 pm
Biogen
Alzheimer's disease
clinical trials
aducanumab
New Biogen data showed no major safety issues for its Alzheimer's drug
Reuters
Thu, 12/5/19 - 12:16 pm
Biogen
safety
Alzheimer's disease
aducanumab
clinical trials
What to watch as Biogen presents its all-important Alzheimer's data
Biopharma Dive
Wed, 12/4/19 - 11:11 pm
Biogen
clinical trials
Alzheimer's disease
aducanumab
'Positive surprise' for Biogen in lupus, but all eyes on CTAD data this week
Fierce Biotech
Tue, 12/3/19 - 10:20 pm
Biogen
AstraZeneca
lupus
Amgen clinical trials
BIIB059
Biogen’s stock could fall 10% on new Alzheimer’s drug data this week, top analyst says
CNBC
Tue, 12/3/19 - 10:18 pm
Biogen
Alzheimer's disease
aducanumab
Analyst: Biogen's aducanumab is not getting approved absent a deus ex machina
Fierce Biotech
Mon, 12/2/19 - 10:44 am
Biogen
aducanumab
FDA
Alzheimer's disease
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
Yahoo/Benzinga
Mon, 12/2/19 - 09:42 am
ASH2019
Roche
Bristol-Myers Squibb
Acadia Pharmaceuticals
Biogen
Cassava Sciences
Alector
GW Pharma
Magenta Therapeutics
Fortress Biotech
Mustang Bio
Bluebird Bio
Why Biogen's Recent Rebound May Not Last -- at Least for Now
Motley Fool
Wed, 11/27/19 - 10:43 am
Biogen
MS
multiple sclerois
Alzheimer's disease
Tecfidera
aducanumab
Pages
« first
‹ previous
…
23
24
25
26
27
28
29
30
31
…
next ›
last »